 |
|
August 20, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- Beyond Air: Signs New International LungFit
PH Distribution Agreements, Most Notably in
Japan More
- Celldex: Results From Phase 2 Study
of Barzolvolimab in Eosinophilic Esophagitis
(EoE) More
More
More*
- CytoSorbents: Updates U.S. FDA Regulatory
Status of DrugSorb-ATR More
- Delcath Systems: First Patient Dosed in
Phase 2 Clinical Trial of HEPZATO in
Liver-Dominant Metastatic Colorectal Cancer More
- Kyowa Kirin: Premiers New CTCL Staging Tool
for Healthcare Providers More
- LinusBio: ClearStrand-ASD First-of-Its-Kind
Autism Screening Tool, Now Available in Japan
More
- Lung Cancer Research Foundation: Expands
Scientific Advisory Board More
- Mitsubishi Tanabe Pharma America:
Publication of Long-Term Function and Survival
Analysis of RADICAVA ORS (edaravone)-Treated
Patients With ALS More
- MSN Pharmaceuticals: Marks Major Milestone
With U.S. Launch of Sacubitril and Valsartan
Tablets Following Hard-Fought Legal Victory More
- NYU Langone Health System: Restricted Blood
Flow Speeds Tumor Growth by Aging the Immune
System
More More
- Parkinson's Foundation: Launches New Program
to Accelerate Clinical Trials More
- PTC Therapeutics: Receives Complete
Response Letter for Vatiquinone NDA More
More
More*
More*
- Qure.ai: Global Healthcare Innovator Expands
Executive Team With Eminent Lung Health
Appointment to Accelerate Clinical Strategy
More
|
|
|
 |
-
- Iantrek: Raises $42 Million Series C
to Launch AlloFlo Uveo, a Breakthrough
Interventional Glaucoma Therapy More
- Intelligent Bio Solutions: Achieves Record
Monthly Sales of 12,500+ Units of
Higher-Margin Cartridges in July
More
- More on VantAI, Halda Therapeutics
Launching $1B+ Proximity-Based Therapy
Collaboration
More
- OS Therapies: Second Quarter 2025 Financial
Results and Business Update More
- Phathom Pharmaceuticals: Clarifies That
There Is No Reduction in Lead Shareholder’s
Ownership Following Administrative Change to
13D Filing More
- Several US Pharma Giants Stage Q2 Sales
Turnaround After Subpar Results Earlier in
Year More
- Tevogen: Delivers Stronger Second Quarter
and First Half 2025 Financial Results With
Reduced Expenses and Growth Momentum
More
- TNF Pharmaceuticals: Strengthens Financial
Position for Growth and Value Creation More
|
|
|
- More on Merck and Daiichi Winning
Breakthrough Status for Ifinatamab Deruxtecan
More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
showcased by Big4Bio. |
|
|
|
|
|
 |
| Organizational
Leader and Business Strategist
Kyle Kinzie Named President &
Partner, Hospitals &
Healthcare Delivery Solutions at
Slone Partners |
|
Learn More
→ |
|
|
- FEATURE: The Changing Landscape of
Diagnostics More
- ICYMI: CEO's Perspective: The Power of
Pivoting More
- ICYMI: Lab Coat to Job Hunt: Scientists
Grapple With Realities of Biotech Downturn,
Pivot Careers More*
- ICYMI: Q&A: AI and Digital
Transformation in Healthcare & Life
Sciences More
- ICYMI: What Defines Great Leadership? More
- ICYMI: The Future of Hiring: How Fractional
Talent Is Reshaping the Workforce More
- ICYMI: Top Manufacturing Jobs in the Pharma
and Biotech Industry More
- Stephen Hahn Steps Down as CEO of Flagship
Biotech; a New Era at AbbVie Partner Gubra More*
|
|
 |
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
